Key result
Asia-Pacific countries show suboptimal management of hypertension, diabetes, and dyslipidemia, with dyslipidemia having the lowest rates.
Why the study?
There is a need to understand the management status of hypertension, dyslipidemia/hypercholesterolemia, and diabetes mellitus in the Asia-Pacific region.
Meta-Analysis
Yes
The management of major cardiovascular risk factors, particularly dyslipidemia, remains suboptimal across the Asia-Pacific region, highlighting a need for improved public health and clinical strategies.
Aim: There is a need to understand the management status of hypertension, dyslipidemia/hypercholesterolemia, and diabetes mellitus in the Asia–Pacific region (APAC). Methods: We conducted a systematic literature review and meta-analysis to summarize the awareness, treatment, and/or control rates of these risk factors in adults across 11 APAC countries/regions. Results: We included 138 studies. Individuals with dyslipidemia had the lowest pooled rates compared with those with other risk factors. Levels of awareness with diabetes mellitus, hypertension, and hypercholesterolemia were comparable. Individuals with hypercholesterolemia had a statistically lower pooled treatment rate but a higher pooled control rate than those with hypertension. Conclusion: The management of hypertension, dyslipidemia, and diabetes mellitus was suboptimal in these 11 countries/regions.
No takes yet. Share an insight, caveat, or question.
Yeh et al. (2023) conducted a meta-analysis in Cardiovascular risk factors (hypertension, dyslipidemia, diabetes mellitus). Cardiovascular risk factor management was evaluated on Awareness, treatment, and/or control rates. Management of hypertension, dyslipidemia, and diabetes mellitus was suboptimal across 138 studies in 11 Asia-Pacific countries, with dyslipidemia having the lowest pooled rates.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: